Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enersize | ENERS | Apr 18, 2024 | 0.01 | 0.00 |
Engcon AB | ENGCONB | Apr 18, 2024 | 79.20 | -0.38 |
Eniro Group | ENRO | Apr 18, 2024 | 0.54 | -3.57 |
Enorama Pharma | ERMA | Apr 18, 2024 | 2.59 | -10.69 |
Enrad | ENRAD | Apr 18, 2024 | 5.50 | 0.00 |
Envirologic B | ENVIB | Apr 18, 2024 | 18.00 | -1.64 |
Enzymatica | ENZY | Apr 18, 2024 | 3.38 | -2.59 |
Eolus Vind B | EOLUB | Apr 18, 2024 | 69.50 | +1.76 |
Ependion AB | EPEN | Apr 18, 2024 | 108.20 | -1.10 |
Epiroc A | EPIA | Apr 18, 2024 | 213.00 | +0.09 |
Epiroc B | EPIB | Apr 18, 2024 | 190.20 | 0.00 |
Episurf Medical B | EPISB | Apr 18, 2024 | 0.71 | +0.28 |
EQL Pharma | EQL | Apr 18, 2024 | 42.20 | -1.86 |
EQT | EQT | Apr 18, 2024 | 289.60 | -5.88 |
Ericsson A | ERICA | Apr 18, 2024 | 56.80 | +1.79 |
Ericsson B | ERICB | Apr 18, 2024 | 55.86 | +1.75 |
ES Energy Save Holding | ESGRB | Apr 18, 2024 | 34.50 | -2.68 |
Essity A | ESSITYA | Apr 18, 2024 | 254.50 | +0.79 |
Essity B | ESSITYB | Apr 18, 2024 | 253.20 | +0.68 |
Euroafrica Digital Ventures | EURA | Apr 18, 2024 | 0.04 | -9.63 |
Eurobattery Minerals | BAT | Apr 18, 2024 | 0.38 | -2.54 |
Eurocine Vaccines | EUCI | Apr 18, 2024 | 0.09 | +95.73 |
European Institute of Science B | EURIB | Apr 18, 2024 | 4.76 | +27.96 |
Everysport Group AB | EVERY | Apr 18, 2024 | 17.50 | +2.04 |
Evolution | EVO | Apr 18, 2024 | 1 295.50 | -0.65 |
Ework Group AB. | EWRK | Apr 18, 2024 | 136.60 | +0.89 |
Exalt | EXALT | Apr 18, 2024 | 0.49 | +9.78 |
ExpreS2ion Biotech Holding | EXPRS2 | Apr 18, 2024 | 2.55 | -7.27 |
Exsitec | EXS | Apr 18, 2024 | 183.00 | -3.68 |
Eyeonid Group | EOID | Apr 18, 2024 | 14.50 | +26.09 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.